Search research articles
Contact Us
Filters
Showing results (311-320 of 350) with videos related to
Page
of 35
Sort By:
The Lancet. Global Health
|
April 27, 2025
Personalised risk-prediction tools for cryptococcal meningitis mortality to guide treatment stratification in sub-Saharan Africa: a prognostic modelling study based on pooled analysis of two randomised controlled trials
Thomas H A Samuels, Sile F Molloy, David S Lawrence, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 22, 2023
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial
David R Boulware, Mucunguzi Atukunda, Enock Kagimu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 4, 2026
Metformin on the Presence of COVID-19 Symptoms 6 Months after Infection: The ACTIV-6 Randomized Clinical Trial
Carolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
JAMA
|
October 21, 2022
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial
Susanna Naggie, David R Boulware, Christopher J Lindsell, et al.
Open Forum Infectious Diseases
|
April 8, 2022
Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic Symptoms
Carolyn T Bramante, Jennifer L Proper, David R Boulware, et al.
Trials
|
January 16, 2019
Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial
David S Lawrence, Nabila Youssouf, Síle F Molloy, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 20, 2025
Metformin on the Presence of COVID-19 Symptoms Over 6 Months: The ACTIV-6 Randomized Clinical Trial
Carolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 23, 2022
Effect of Ivermectin 600 μg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial
Susanna Naggie, David R Boulware, Christopher J Lindsell, et al.
Trials
|
November 25, 2018
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial
David S Lawrence, Nabila Youssouf, Síle F Molloy, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 4, 2023
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up
Carolyn T Bramante, John B Buse, David Liebovitz, et al.
Page
of 35
Search research articles
Search
Showing results (311-320 of 350) with videos related to
Sort By:
Page
of 35
The Lancet. Global Health
|
April 27, 2025
Personalised risk-prediction tools for cryptococcal meningitis mortality to guide treatment stratification in sub-Saharan Africa: a prognostic modelling study based on pooled analysis of two randomised controlled trials
Thomas H A Samuels, Sile F Molloy, David S Lawrence, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 22, 2023
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial
David R Boulware, Mucunguzi Atukunda, Enock Kagimu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 4, 2026
Metformin on the Presence of COVID-19 Symptoms 6 Months after Infection: The ACTIV-6 Randomized Clinical Trial
Carolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
JAMA
|
October 21, 2022
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial
Susanna Naggie, David R Boulware, Christopher J Lindsell, et al.
Open Forum Infectious Diseases
|
April 8, 2022
Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic Symptoms
Carolyn T Bramante, Jennifer L Proper, David R Boulware, et al.
Trials
|
January 16, 2019
Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial
David S Lawrence, Nabila Youssouf, Síle F Molloy, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 20, 2025
Metformin on the Presence of COVID-19 Symptoms Over 6 Months: The ACTIV-6 Randomized Clinical Trial
Carolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 23, 2022
Effect of Ivermectin 600 μg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial
Susanna Naggie, David R Boulware, Christopher J Lindsell, et al.
Trials
|
November 25, 2018
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial
David S Lawrence, Nabila Youssouf, Síle F Molloy, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 4, 2023
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up
Carolyn T Bramante, John B Buse, David Liebovitz, et al.
Page
of 35